Segment Reporting - Operating Income (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023
Segment Reporting Information [Line Items]
Net sales	$ 339,845			$ 315,230			$ 1,001,356	$ 932,851
Income from operations	37,261			35,137			119,129	90,332
Total other expense - net	(604)			(4,915)			(2,281)	(9,710)
Income tax expense	8,213			4,388			24,438	13,840
Net income	28,444	$ 35,726	$ 28,240	25,834	$ 20,245	$ 20,703	92,410	66,782
Cardiovascular
Segment Reporting Information [Line Items]
Net sales	322,855			306,084			964,044	905,335
Income from operations	37,555			32,622			113,374	82,966
Endoscopy
Segment Reporting Information [Line Items]
Net sales	16,990			9,146			37,312	27,516
Income from operations	$ (294)			$ 2,515			$ 5,755	$ 7,366